LYSOGENE

December 23, 2020

Voyager hold adds to gene therapy woes

December 20, 2019

Plenty of choice remains for buyers of gene therapy

Despite the recent flurry of gene therapy deals there is still a fairly extensive list of affordable companies out there.

April 12, 2017

First-quarter floats see haves pulling away from the have-nots

Demand for new issues remains sluggish - only eight private biotechs managed to pull off an IPO in the first quarter of 2017.

February 26, 2014

Therapeutic focus – Gene therapy slowly rises from the ashes